Creatine for Brain Health: What the Research Actually Shows

This article separates creatine's well-supported muscle effects from its more preliminary cognitive effects, and is general information rather than a recommendation to supplement.

Creatine is one of the most studied sports supplements, and its effect on muscle and high-intensity exercise is among the most reproducible findings in sports nutrition. Its effect on the brain is a separate and much younger question. The honest summary is that the muscle evidence is strong and the cognitive evidence is promising but preliminary, with benefits concentrated in specific situations rather than across the board.

This article keeps those two threads apart on purpose, because much of the recent enthusiasm for "creatine for the brain" treats them as if they were the same body of evidence. They are not.

The short answer

Creatine appears most likely to help cognition when the brain is under stress, for example during sleep deprivation, or when baseline brain creatine may be lower than usual, as in some vegetarians and possibly some older adults [Gordji-Nejad 2024; Rae 2003]. In rested, well-nourished young adults, the results are mixed and often null [Xu 2024; Prokopidis 2023].

The mechanism is plausible: creatine supports the cell's rapid energy-buffering system, and the brain is an energy-hungry organ. But supplementing reliably raises brain creatine by far less than it raises muscle creatine, which may explain why cognitive effects are smaller, less consistent, and possibly dependent on higher doses than those used for muscle [Dechent 1999; Forbes 2022]. The cognitive question is genuinely open, and it should not be sold as settled.

How creatine works

Creatine is a compound made in the body from amino acids and also obtained from meat and fish. Inside cells it exists partly as free creatine and partly as phosphocreatine. Phosphocreatine acts as a short-term energy reserve: it can rapidly regenerate adenosine triphosphate (ATP), the molecule cells use for immediate energy, during bursts of high demand. This is the phosphocreatine energy system, and it is why creatine matters most where energy turnover spikes quickly.

Muscle is the obvious example, but the brain runs on the same currency. Neurons have high and fluctuating energy demands, and they also rely on the creatine–phosphocreatine system to buffer ATP. The brain even makes some of its own creatine and tightly controls how much crosses in from the bloodstream, which is part of why supplementing the brain is harder than supplementing muscle [Roschel 2021].

Two facts shape everything that follows. First, supplementation raises brain creatine, but modestly. Imaging studies using magnetic resonance spectroscopy have found increases of roughly 5 to 10 percent in the brain after several weeks of supplementation, compared with the roughly 20 percent often seen in muscle [Dechent 1999; Roschel 2021]. Second, that measured signal is a composite of creatine and phosphocreatine and cannot fully separate the two, so the imaging picture is less precise than headlines imply.

The well-established part: muscle and performance

Before the cognitive evidence, it is worth grounding the discussion in what creatine is actually known to do, because that is the strong evidence people are borrowing from.

Creatine monohydrate increases intramuscular creatine stores and can improve performance in repeated high-intensity efforts and resistance training, and it can support training adaptations over time. The International Society of Sports Nutrition position stand describes creatine monohydrate as the most effective ergogenic nutritional supplement available for increasing high-intensity exercise capacity and lean body mass during training, and reports that short- and long-term supplementation, up to 30 g per day for five years in some studies, has been well tolerated in healthy people across a range of ages [Kreider 2017].

That is a high bar of evidence: many trials, consistent direction, a clear mechanism, and a long safety record. The cognitive literature does not yet meet it. Understanding why is useful, and our guide on how to read a clinical trial covers the design features, sample size, blinding, and pre-registration, that separate a strong result from a fragile one.

The cognition evidence, situation by situation

The most useful way to read the cognitive literature is not "does creatine make you smarter" but "under what conditions, in whom, does it change a measured outcome." The answer varies a lot by population and by how stressed the brain is at the time of testing.

Where it looks most promising

Sleep deprivation. This is currently one of the more striking findings. In a 2024 trial, a single high dose of creatine (0.35 g per kilogram of bodyweight) given during a night of sleep deprivation improved measures of processing speed and short-term memory relative to placebo, with changes also seen in brain high-energy phosphate markers. Effects appeared within a few hours and lasted up to around nine hours [Gordji-Nejad 2024]. This is interesting partly because it challenges the assumption that creatine only works after weeks of loading, but it was a small study (15 participants) and needs replication before anyone treats acute high-dose creatine as a fatigue countermeasure.

Vegetarians and lower dietary intake. Because creatine comes largely from meat and fish, people who eat little or none tend to have lower baseline stores and may have more room to respond. In an early double-blind, placebo-controlled crossover trial, 5 g per day for six weeks improved working memory and a measure of reasoning in vegetarian young adults [Rae 2003]. The signal in groups with lower baseline intake is one of the more consistent threads in the literature, though it still rests on a modest number of studies.

Older adults. Some reviews suggest cognitive benefits, particularly for memory and attention, appear more often in older adults than in young ones, possibly because of age-related changes in brain energy metabolism [Prokopidis 2023; Candow 2023]. A recent systematic review of older-adult studies found that most reported a positive relationship between creatine and at least one cognitive domain. This is promising rather than proven: the trials are small and varied, and the field has not converged on dose or duration.

Where results are null or mixed

In rested, well-nourished young adults, the picture is much weaker. Several trials show no clear cognitive benefit, and meta-analyses that pool across populations tend to find small or inconsistent effects that are sensitive to how the data are handled [Xu 2024; Prokopidis 2023].

This last point matters. The 2023 memory meta-analysis initially reported a favourable overall effect, but subsequent statistical scrutiny, addressing the problem of counting multiple non-independent outcomes from the same participants, narrowed the apparent benefit, with the clearest remaining signal in older adults rather than across all groups [Prokopidis 2023]. Regulatory and methodological commentators have raised similar concerns about drawing firm conclusions from the current meta-analytic base. If you want to understand why a single pooled number can be fragile, our explainer on how to evaluate a meta-analysis walks through heterogeneity, double-counting, and publication bias.

Clinical and injury contexts

There is early, mostly preliminary work in clinical settings. A small open-label randomised pilot study in children and adolescents with traumatic brain injury reported improvements across several recovery measures, including cognitive function, with creatine given over six months [Sakellaris 2006]. This is suggestive, but it was small, open-label rather than blinded, and conducted in a specific clinical population recovering from injury. It does not translate into a claim about cognition in healthy people, and it does not establish creatine as a treatment for any condition.

What the evidence shows by population

Evidence strength here reflects the quantity, consistency, and quality of the human trials, not the size of any single reported effect.

Dose for the brain

A recurring theme is that the brain may need more than the muscle does. The standard muscle protocol is roughly 3 to 5 g per day of creatine monohydrate, sometimes preceded by a higher loading phase. But because brain creatine rises less than muscle creatine in response to the same intake, several researchers have suggested that meaningful cognitive effects might require higher daily doses, longer durations, or both [Forbes 2022; Candow 2023].

This is a hypothesis, not an established protocol. We do not yet have well-powered trials that have systematically compared doses for cognitive outcomes and identified an optimal one. The studies that show acute effects under stress used large single doses [Gordji-Nejad 2024], while the studies in vegetarians and older adults used more conventional daily amounts [Rae 2003]. Anyone reading "you need 10 grams for your brain" should treat it as a reasonable line of inquiry rather than a tested fact. The gap between "biologically plausible" and "demonstrated in humans" is exactly where supplement marketing tends to overreach, a pattern we describe in how "evidence-based" gets misused.

Safety

Creatine monohydrate has one of the better safety records among studied supplements. The ISSN position stand concludes that supplementation, including long-term use, has been well tolerated in healthy people, and that it does not damage kidney function in those with healthy kidneys [Kreider 2017]. Mild water retention or gastrointestinal discomfort, particularly with large single doses, are the most commonly reported effects.

Several caveats apply. Most safety data come from healthy adults; people with kidney disease, those who are pregnant or breastfeeding, and anyone on medication should treat that data as not directly applicable to them. Product quality varies, and creatine monohydrate is the form with by far the most evidence behind it; novel or "enhanced" forms generally do not have comparable testing. And as with any supplement, "well tolerated in trials" is not the same as "appropriate for you specifically."

The measured bottom line

For muscle and high-intensity performance, creatine monohydrate is well supported, and that is not really in dispute. For cognition, the position is more modest and more honest stated plainly: there is a credible mechanism, there are encouraging human findings in specific situations, sleep deprivation, lower dietary intake, possibly ageing, and there is a genuine absence of convincing effects in rested, well-fed young adults [Xu 2024; Roschel 2021]. The cognitive case rests on fewer trials, smaller samples, and results that shift depending on the statistics used.

Promising is the right word, and so is preliminary. Both can be true at once. If you are interested in creatine, the strongest evidence-based reason to consider it remains physical performance and training, where it also intersects with what recovery actually means and with the wider performance literature. The cognitive benefits, if they hold up, are likely to be situational rather than a general upgrade, and the research has not yet earned the confident headlines being written about it.

Related Proco pages

• What recovery actually means
• How to read a clinical trial
• How to evaluate a meta-analysis
• How "evidence-based" gets misused

Sources

If you are considering creatine, particularly alongside medication or an existing health condition, discuss it with a qualified healthcare professional first.